Virtual Medicinal Product (VMP) - Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials Start Date 27-05-2004 End Date
Previous Name Previous Name Imipenem 500mg / Cilastatin 500mg injection vials Start Date 16-05-2003 End Date 26-05-2004
Abbreviated Name Abbreviated Name Imipenem 500mg / Cilastatin 500mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Imipenem 500mg / Cilastatin 500mg pdr for susp for inj vials Previous Start Date 09-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder for suspension for injection
Ontology Form/Route
suspensioninjection.intramuscular-deep
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
J01DH51
BNF Start Date End Date
Current BNF 05010202 Start Date 04-04-2022 End Date
Previous BNF 05010200 Start Date 01-02-2005 End Date 17-11-2008
SNOMED Codes
Code Start Date End Date
41950811000001108 09-06-2023
323970005 16-08-2005 08-06-2023
4396111000001109 16-05-2003 15-08-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Cilastatin sodium Based on Base Substance Cilastatin 500 mg
Imipenem monohydrate Based on Base Substance Imipenem 500 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial